NRx Receives Nasdaq Notice of Listing Compliance ...Middle East

PR Newswire - News
NRx Receives Nasdaq Notice of Listing Compliance
RADNOR, Pa., Dec. 2, 2022 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced it received written notice on December 1, 2022 from The Nasdaq Stock Market informing NRx Pharmaceuticals...

Hence then, the article about nrx receives nasdaq notice of listing compliance was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( NRx Receives Nasdaq Notice of Listing Compliance )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News